Here begins the text.

The 2nd Malaysia-Japan Symposium

June 13, 2022
Pharmaceuticals and Medical Devices Agency

Purpose

Globalization of research and development, manufacturing and marketing of medical products has progressed, and cooperation in regulatory activities amongst regulatory agencies has become more and more important. Nowadays, Asian countries have become significant in the area of clinical development and manufacturing of medical products, and therefore, PMDA strives to strengthen the collaborative relationship with the Asian regulatory agencies.
PMDA and the National Pharmaceutical Regulatory Agency (NPRA) held the 1st Malaysia-Japan Symposium in 2015. This symposium is planned and organized to tighten the mutual relationship and the cooperative framework for regulation of medical products and to promote thorough understanding of regulatory systems of the two host countries.
This symposium will offer in-depth presentations and discussions in each area from the pharmaceutical regulatory perspective.

Host

(Japan side)
Pharmaceuticals and Medical Devices Agency (PMDA)

(Malaysia side)
National Pharmaceutical Regulatory Agency (NPRA)

Support

(Japan side)
Japan Pharmaceutical Manufacturers Association (JPMA)
Forum for Innovative Regenerative Medicine (FIRM)
 
(Malaysia side)
Malaysian Pharmacist’s Society (MPS)
 

Date

14th July, 2022

Venue

The symposium will be held by virtual (WebEx).
Participants will receive the link by email.

Registration

Registration is now closed

Online Registration Click : https://forms.gle/Hu4PKfnVkE61uTzQA
Deadline 28th June, 2022

* Please note the number of participants is limited. In case the number of applicant is exceed the capacity, we may not be able to meet a request.

Interpretation

Simultaneous interpretation (English-Japanese/Japanese-English)

Agenda

Please see attached, for the details of the program.

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.